Short answer · Medically reviewed summary · Last updated: 2026-05-08
Growth Hormone Deficiency (GHD) is clinically categorized under ICD-10 code E23.0 for hypopituitarism, which encompasses isolated growth hormone deficiency. In the older ICD-9 coding system, Growth Hormone Deficiency is primarily represented by code 253.3. How is Growth Hormone Deficiency classified in medical records? In clinical practice, Growth Hormone Deficiency is often identified by specific billing codes to facilitate insurance coverage for diagnostic testing and recombinant human growth hormone (rhGH) therapy.
ICD10 code of Growth Hormone Deficiency and ICD9 code
ICD-10 and ICD-9 codes for Growth Hormone Deficiency, with classification details for clinicians, coders and patients.
Growth Hormone Deficiency (GHD) is clinically categorized under ICD-10 code E23.0 for hypopituitarism, which encompasses isolated growth hormone deficiency. In the older ICD-9 coding system, Growth Hormone Deficiency is primarily represented by code 253.3.
How is Growth Hormone Deficiency classified in medical records?
In clinical practice, Growth Hormone Deficiency is often identified by specific billing codes to facilitate insurance coverage for diagnostic testing and recombinant human growth hormone (rhGH) therapy. While ICD-10 E23.0 is the standard for Growth Hormone Deficiency, physicians may also use E23.1 (drug-induced hypopituitarism) if the condition is secondary to other treatments. Accurately coding for Growth Hormone Deficiency is essential for accessing specialized pediatric endocrinology services.
What are the clinical markers of Growth Hormone Deficiency?
Growth Hormone Deficiency manifests primarily through significantly slowed growth velocity and short stature. Patients often present with specific physiological indicators that guide clinicians toward a formal diagnosis:
- Growth velocity below the 3rd percentile for age and sex.
- Delayed bone age as determined by X-ray (typically left hand and wrist).
- Low serum levels of Insulin-like Growth Factor-1 (IGF-1).
- Subnormal peak growth hormone response to provocative stimulation testing.
Is Growth Hormone Deficiency considered a rare condition?
The prevalence of Growth Hormone Deficiency is estimated to be between 1 in 4,000 and 1 in 10,000 children. Within the DiseaseMaps.org community, 58 people with Growth Hormone Deficiency have joined to share their personal experiences, highlighting the importance of peer support for families navigating the complexities of Growth Hormone Deficiency management and long-term treatment protocols.
Next steps
- Consult a board-certified pediatric endocrinologist for specialized hormone stimulation testing.
- Request a bone age assessment to track skeletal maturity.
- Join the DiseaseMaps.org community to connect with other families managing Growth Hormone Deficiency.
- Review your insurance policy regarding the coverage of daily rhGH injections.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Growth Hormone Deficiency.
- Orphanet: Isolated Growth Hormone Deficiency (ORPHA:365).
- OMIM (Online Mendelian Inheritance in Man): Growth Hormone Deficiency, Isolated.
- The MAGIC Foundation: Educational resources for growth hormone disorders.
